Tags

Type your tag names separated by a space and hit enter

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies.
Cell Mol Immunol. 2021 Apr; 18(4):1061-1063.CM

Links

PMC Free PDF

Authors+Show Affiliations

Hu J
Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Peng P
Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Wang K
Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Fang L
Yong-Chuan Hospital, Chongqing Medical University, Chongqing, China.
Luo FY
Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
Jin AS
Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
Liu BZ
Yong-Chuan Hospital, Chongqing Medical University, Chongqing, China. liubeizhong@cqmu.edu.cn.
Tang N
Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. nitang@cqmu.edu.cn.
Huang AL
Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. ahuang@cqmu.edu.cn.

MeSH

Antibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralCOVID-19Cell Line, TumorConvalescenceHumansSARS-CoV-2Spike Glycoprotein, Coronavirus

Pub Type(s)

Letter

Language

eng

PubMed ID

33633321

Citation

Hu, Jie, et al. "Emerging SARS-CoV-2 Variants Reduce Neutralization Sensitivity to Convalescent Sera and Monoclonal Antibodies." Cellular & Molecular Immunology, vol. 18, no. 4, 2021, pp. 1061-1063.
Hu J, Peng P, Wang K, et al. Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies. Cell Mol Immunol. 2021;18(4):1061-1063.
Hu, J., Peng, P., Wang, K., Fang, L., Luo, F. Y., Jin, A. S., Liu, B. Z., Tang, N., & Huang, A. L. (2021). Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies. Cellular & Molecular Immunology, 18(4), 1061-1063. https://doi.org/10.1038/s41423-021-00648-1
Hu J, et al. Emerging SARS-CoV-2 Variants Reduce Neutralization Sensitivity to Convalescent Sera and Monoclonal Antibodies. Cell Mol Immunol. 2021;18(4):1061-1063. PubMed PMID: 33633321.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies. AU - Hu,Jie, AU - Peng,Pai, AU - Wang,Kai, AU - Fang,Liang, AU - Luo,Fei-Yang, AU - Jin,Ai-Shun, AU - Liu,Bei-Zhong, AU - Tang,Ni, AU - Huang,Ai-Long, Y1 - 2021/02/25/ PY - 2021/1/24/received PY - 2021/1/29/accepted PY - 2021/2/27/pubmed PY - 2021/4/23/medline PY - 2021/2/26/entrez SP - 1061 EP - 1063 JF - Cellular & molecular immunology JO - Cell Mol Immunol VL - 18 IS - 4 SN - 2042-0226 UR - https://www.unboundmedicine.com/medline/citation/33633321/Emerging_SARS_CoV_2_variants_reduce_neutralization_sensitivity_to_convalescent_sera_and_monoclonal_antibodies_ DB - PRIME DP - Unbound Medicine ER -